Jun Yuan

Jan 8, 2025 | nature.com | Jun Yuan

AbstractKidney renal clear cell carcinoma (KIRC) is the most prevalent subtype of kidney cancer. Although multiple therapeutic agents have been proven effective in KIRC, their clinical application has been hindered by a lack of reliable biomarkers. This study focused on the prognostic value and function of drug absorption, distribution, metabolism, and excretion- (ADME-) related genes (ARGs) in KIRC to enhance personalized therapy.

Dec 4, 2024 | thesingaporeaninvestor.sg | Jun Yuan

2024 is coming to an end in another 3+ weeks. It has been an extremely busy year, but at the same time, a very fulfilling one for me. I hope the year has been a fruitful one for you as well. Just like in the previous years, there are ‘hits’, as well as ‘misses’, and in this final post of 2024 (I will be going on a family holiday to France and Switzerland next Thursday, 12 December [at the same time celebrating my 15th year wedding anniversary with my wife a day after].

Nov 10, 2024 | thesingaporeaninvestor.sg | Jun Yuan

All 3 banks have already released their business update for the 3rd quarter, and for the first 9 months of FY2024 ended 30 September – starting with DBS (SGX: D05) last Thursday (07 November), followed by UOB (SGX: U11) and OCBC (SGX: O39) a day after (Friday, 08 November). I have posted my reviews of their results as they were made available.

Oct 22, 2024 | thesingaporeaninvestor.sg | Jun Yuan

Mapletree Logistics Trust (SGX: M44U), or MLT for short, is the first of the trio of Mapletree REITs to release its results for the 2nd quarter, as well as for the first half of the fiscal year ended 30 September 2024 yesterday evening (22 October) – for information, Mapletree Pan Asia Commercial Trust will be reporting its results tomorrow (24 October) evening, and then Mapletree Industrial Trust next Tuesday (29 October) evening. For the uninitiated, MLT invests in logistics properties in Asia.

Aug 12, 2024 | thesingaporeaninvestor.sg | Jun Yuan

We are in the middle of the earnings season right now, with a good number of Singapore-listed companies having already reported their business updates or full financial results for the quarter ended 30 June. Among them include the 3 Singapore banks (in DBS, UOB, and OCBC), and you can find my detailed review of their results in this post – How DBS, UOB, and OCBC Fared in Q2 and 1H FY2024.